针对晚期非小细胞肺癌的精密药物管理建议:专家共识
Hampig Raphael Kourie1, Mounir Ahmed Bachouchi2, Malika Makhlouf Gamaz3
1Hematology-Oncology Department, Faculty of Medicine, Saint Joseph University of Beirut, Beirut, Lebanon.
Future oncology (London, England)
|June 27, 2025
概括
这份专家共识为中东和北非 (MENA) 地区的高级非小细胞肺癌 (NSCLC) 提供了量身定制的建议. 这些指导方针旨在通过基于证据的策略和精准医学来改善患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 公共卫生 公共卫生
- 医学指导方针 医学指导方针
背景情况:
- 肺癌是全球癌症死亡的主要原因,也是第二常见的癌症.
- 非小细胞肺癌 (NSCLC) 占肺癌病例的85%.
- 在中东和北非 (MENA) 地区,肺癌的发病率和死亡率很高,五年生存率很低 (8%).
研究的目的:
- 制定针对中东和北非地区的高级非小细胞肺癌 (NSCLC) 管理的区域性定制建议.
- 为应对中东和北非地区肺癌迫切的健康挑战.
- 为改善患者治疗结果提供一个框架.
主要方法:
- 召开了一个由15名区域专家组成的小组.
- 经过修改的Delphi过程被用来开发基于证据的指导.
- 制定了40个共识声明,涵盖流行病学,诊断,分子测试和向治疗.
主要成果:
- 共识声明将全球最佳实践与特定区域的考虑相结合,包括获得测试和治疗.
- 这些建议为中东和北非地区先进的NSCLC管理提供了第一个区域适应的框架.
- 涵盖的关键领域包括流行病学,诊断工作,分子测试和向治疗.
结论:
- 制定的指导方针旨在统一临床实践,并促进MENA地区高级NSCLC的精密医学.
- 这些建议旨在支持临床医生提高患者护理和改善结果.
- 这种共识为在MENA地区解决NSCLC问题提供了一个关键的框架.
更多相关视频
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
10.6K
07:42Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
Published on: February 7, 2021
5.1K
相关概念视频
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Chronic Obstructive Pulmonary Disease-V: Management
2.7K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.7K
